Healthcare and Life Science
Team’s hip replacement surgery invention is set to be world first
Technology which is the first of its kind in the world and could transform the future of hip replacement surgery is being pioneered by a team of experts in Cambridge. ...
Owlstone Medical celebrates success at SME Cambridgeshire Business Awards
It was a double success as the Owlstone Medical team scooped two awards. The company won Website of the Year for its OMED Health website and silver for Employer of the Year. ...
Nxera’s Partner Cancer Research UK to Present on Phase 1/2a Clinical Trial with Cancer Immunotherapy Drug HTL0039732 at ESMO
HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist with the potential to treat a wide range of cancers in combination with other immunotherapies Cancer Research UK’s Centre for Drug Development is sponsoring and managing the ongoing Phase 1/2a clinical trial o...
New therapy that targets and destroys tau tangles is a promising future Alzheimer’s disease treatment
Medical Research Council media release.
Cambridge Enterprise appoints new Chief Executive
Dr Jim Glasheen has been appointed as Chief Executive of Cambridge Enterprise, the innovation arm of the University of Cambridge. Dr Glasheen will assume his post later in 2024. ...
New state-of-the-art radiotherapy equipment benefiting patients in the East
Cancer patients undergoing treatment at Norfolk and Norwich University Hospital’s NHS Foundation Trust (NNUH) and Cambridge University Hospitals NHS Foundation Trust (CUH) are benefiting from a new type of radiotherapy which reduces treatment time whilst increasing accuracy and patient ...
Breast and ovarian cancer newly linked to thousands of gene variants
Scientists have pinpointed thousands of genetic changes in a gene that may increase a person’s risk of developing breast and ovarian cancer, paving the way for better risk assessment and more personalised care. ...
Significant progress made in meeting demand for lab and office space
A joint news release on behalf of Cambridge City Council and South Cambridgeshire District Council and Greater Cambridge Shared Planning. ...
Mission Street and BGO get go-ahead for 23-acre central Cambridge science district
CAMBRIDGE, UK - In a significant step forward for the UK’s aspirations to be a ‘science superpower’, specialist investor, developer and operator for the science and innovation sector Mission Street and BGO, a leading global real estate investment manager, received planning consent to de...